Quick Answer
PALVELLA THERAPEUTICS, INC. reported Operating Income of -$38.60 million for fiscal year 2025.
PALVELLA THERAPEUTICS, INC. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$38.60M | -173.9% |
| 2024 | -$14.10M | -18.8% |
| 2023 | -$11.87M | +72.7% |
| 2022 | -$43.47M | +16.1% |
| 2021 | -$51.83M | -52.8% |
| 2020 | -$33.92M | -24.9% |
| 2019 | -$27.16M | +11.9% |
| 2018 | -$30.83M | -111.3% |
| 2017 | -$14.59M | +35.9% |
| 2016 | -$22.76M | -66.4% |
| 2015 | -$13.68M | -90.1% |
| 2014 | -$7.20M | -45713.8% |
| 2014 | -$15.7K | -102.8% |
| 2013 | $553.8K | +202226.3% |
| 2013 | -$274.00 | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$10.18M | -101.0% | -10.0% |
| June 30, 2025 | -$9.25M | -218.1% | -17.5% |
| March 31, 2025 | -$7.87M | -347.5% | -55.5% |
| September 30, 2024 | -$5.06M | +57.1% | -74.1% |
| June 30, 2024 | -$2.91M | -241.0% | -65.3% |
| March 31, 2024 | -$1.76M | +88.7% | +85.1% |
| September 30, 2023 | -$11.81M | +3.0% | -672.3% |
| June 30, 2023 | $2.06M | +116.7% | +113.3% |
- PALVELLA THERAPEUTICS, INC. showed a decrease of -173.9% in Operating Income compared to the prior fiscal year.
- Over the 2013–2025 period, PALVELLA THERAPEUTICS, INC.’s operating income has declined by 14088221.2% (from -$274.00 to -$38.60 million).
- The most recent figure is from PALVELLA THERAPEUTICS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: